RCM Diligence — Checklist
Orchestration layer · auto-tracked from live analytics
🛡️ Public data only — no PHI permitted on this instance.
Diligence Checklist
Coverage + Open Questions
Auto-tracked from live analytics · partner overrides via URL
7 P0 items still open + 8 P1 — P0 coverage 73%. Do not schedule IC until P0 = 100%.
How to read: P0 coverage is the single go/no-go gauge for IC. Items tied to analytics auto-mark DONE when the analytic is run. Manual items (management references, legal review) need an explicit override — "Mark done" link on each row. All overrides are URL-encoded so you can share a state snapshot by copying the URL.
P0 coverage
73%
Blocking IC
Total done
22/40
55% of all items
Open P0
7
must close before IC
Open P1
8
assign owners
Open questions for IC (15)
Every P0/P1 item that remains OPEN or BLOCKED. This list is what the IC Packet "Open Questions" section prints — close the loop on each before the memo ships.
P0Has the HCRIS-Native Peer X-Ray benchmarked the target against 25-50 filed Medicare cost reports?ANALYST
P0Seller legal review — corporate structure, equity rollover, reps + warranties — signed off?LEGAL
P0Commercial payer contract review — top-5 payer contracts' carveouts, escalators, termination clauses, auto-renewal?LEGAL
P0Has the Regulatory Calendar × Thesis Kill-Switch been run to map upcoming CMS / OIG / FTC / DOJ / NSA-IDR events to the target's thesis drivers?ANALYST
P0Has the Covenant & Capital Stack Stress Lab been run to quantify per-quarter covenant-breach probability and equity-cure sizing?ANALYST
P0Quality-of-Earnings memo drafted and reviewed?PARTNER
P0IC Packet assembled (12 sections with partner synthesis + walkaway + open questions)?PARTNER
P1Cost to collect benchmarked against HFMA peer median?ANALYST
P1TEAM (CMS Transforming Episode Accountability) exposure reviewed?ANALYST
P1Labor + referral leakage reviewed (synthetic FTE, wage inflation, referral concentration)?ANALYST
P1Management team reference calls (CEO / CFO / RCM-ops director) completed?PARTNER
P1Real estate title + environmental + survey report for every owned facility?EXTERNAL
P1Seller disclosure schedule review — pending litigation, regulatory audits, DOJ/OIG matters?LEGAL
P1Has the Payer Mix Stress Lab stress-tested the target's commercial + government payer portfolio?ANALYST
P1Normalised working-capital target estimated + reconciled to seller's proposed peg?ANALYST
Items by phase · click an evidence link to drill in
Phase 1 · Pre-NDA screening
3/4 done · 75%
DONEP0
Has the Bankruptcy-Survivor Scan been run against the 12 named failure patterns?
SCREENING
ANALYST
DONEP0
Has a historical-analog signature match been run (Deal Autopsy)?
SCREENING
ANALYST
DONEP1
Is the sector sentiment from the market-intel feed consistent with the deal thesis?
SCREENING
ANALYST
Phase 2 · CCD benchmarks + predictive
9/11 done · 82%
DONEP0
Has the Canonical Claims Dataset been ingested from the seller's 837/835 files?
INGEST
ANALYST
DONEP0
Days in A/R benchmarked against HFMA peer median?
BENCHMARKS
ANALYST
DONEP0
First-pass denial rate benchmarked against HFMA peer median?
BENCHMARKS
ANALYST
OPENP1
Cost to collect benchmarked against HFMA peer median?
BENCHMARKS
ANALYST
IN PROGRESSP1
Cohort liquidation curve computed (shows cohort censoring + liquidation tail)?
BENCHMARKS
ANALYST
DONEP0
Quality-of-Revenue waterfall reconciliation run against management revenue?
BENCHMARKS
ANALYST
DONEP0
Claim-level denial prediction model trained and calibrated?
PREDICTIVE
ANALYST
Phase 3 · Risk workbench + manual diligence
6/17 done · 35%
IN PROGRESSP1
Corporate Practice of Medicine (CPOM) state exposure assessed?
RISK
LEGAL
DONEP0
No Surprises Act exposure assessed (OON share + IDR arbitration exposure)?
RISK
ANALYST
DONEP0
Real-estate Steward Score computed (sale-leaseback risk + EBITDAR coverage)?
RISK
ANALYST
OPENP1
TEAM (CMS Transforming Episode Accountability) exposure reviewed?
RISK
ANALYST
DONEP0
Antitrust / HHI concentration check for the target's footprint?
RISK
LEGAL
DONEP0
Physician comp benchmarked against FMV p25/p50/p75 + Stark red-lines checked?
RISK
LEGAL
OPENP1
Labor + referral leakage reviewed (synthetic FTE, wage inflation, referral concentration)?
RISK
ANALYST
OPENP1
Management team reference calls (CEO / CFO / RCM-ops director) completed?
MANUAL
PARTNER
OPENP0
Seller legal review — corporate structure, equity rollover, reps + warranties — signed off?
MANUAL
LEGAL
OPENP0
Commercial payer contract review — top-5 payer contracts' carveouts, escalators, termination clauses, auto-renewal?
MANUAL
LEGAL
OPENP1
Real estate title + environmental + survey report for every owned facility?
MANUAL
EXTERNAL
OPENP1
Seller disclosure schedule review — pending litigation, regulatory audits, DOJ/OIG matters?
MANUAL
LEGAL
OPENP0
Has the Regulatory Calendar × Thesis Kill-Switch been run to map upcoming CMS / OIG / FTC / DOJ / NSA-IDR events to the target's thesis drivers?
RISK
ANALYST
Phase 4 · Financial synthesis
4/6 done · 67%
DONEP0
EBITDA bridge with 7 levers built (denial reduction, coding uplift, contract yield, WC optimization, labor inflation, reg-headwind, cyber reserve)?
FINANCIAL
ANALYST
DONEP0
Deal Monte Carlo run (3000 trials, 5-year forward MOIC/IRR distribution, variance attribution, sensitivity tornado)?
FINANCIAL
ANALYST
DONEP0
Counterfactual Advisor — offer-shape modifications to flip every RED/CRITICAL finding?
FINANCIAL
PARTNER
DONEP1
Public-operator comps + transaction multiples pulled for the target's category?
MARKET
ANALYST
OPENP1
Normalised working-capital target estimated + reconciled to seller's proposed peg?
FINANCIAL
ANALYST
Phase 5 · Partner deliverables
0/2 done · 0%
Flat view · sortable · filterable · CSV export
| Item | Phase | Category | Priority | Status | Owner | Question |
|---|---|---|---|---|---|---|
| scan_bankruptcy_survivor | 1 | SCREENING | P0 | DONE | ANALYST | Has the Bankruptcy-Survivor Scan been run against the 12 named failure patterns? |
| scan_deal_autopsy | 1 | SCREENING | P0 | DONE | ANALYST | Has a historical-analog signature match been run (Deal Autopsy)? |
| scan_sector_sentiment | 1 | SCREENING | P1 | DONE | ANALYST | Is the sector sentiment from the market-intel feed consistent with the deal thesis? |
| ingest_ccd | 2 | INGEST | P0 | DONE | ANALYST | Has the Canonical Claims Dataset been ingested from the seller's 837/835 files? |
| benchmark_days_in_ar | 2 | BENCHMARKS | P0 | DONE | ANALYST | Days in A/R benchmarked against HFMA peer median? |
| benchmark_denial_rate | 2 | BENCHMARKS | P0 | DONE | ANALYST | First-pass denial rate benchmarked against HFMA peer median? |
| benchmark_ar_aging | 2 | BENCHMARKS | P0 | DONE | ANALYST | A/R aging > 90 days benchmarked? |
| benchmark_cost_to_collect | 2 | BENCHMARKS | P1 | OPEN | ANALYST | Cost to collect benchmarked against HFMA peer median? |
| benchmark_net_revenue_realization | 2 | BENCHMARKS | P0 | DONE | ANALYST | Net revenue realization benchmarked? |
| benchmark_cohort_liquidation | 2 | BENCHMARKS | P1 | IN PROGRESS | ANALYST | Cohort liquidation curve computed (shows cohort censoring + liquidation tail)? |
| benchmark_denial_pareto | 2 | BENCHMARKS | P1 | DONE | ANALYST | Denial Pareto root-cause table produced? |
| benchmark_qor_waterfall | 2 | BENCHMARKS | P0 | DONE | ANALYST | Quality-of-Revenue waterfall reconciliation run against management revenue? |
| predictive_denial_model | 2 | PREDICTIVE | P0 | DONE | ANALYST | Claim-level denial prediction model trained and calibrated? |
| predictive_physician_attrition | 2 | PREDICTIVE | P0 | DONE | ANALYST | Physician flight-risk (P-PAM) scored across the roster? |
| risk_cpom | 3 | RISK | P1 | IN PROGRESS | LEGAL | Corporate Practice of Medicine (CPOM) state exposure assessed? |
| risk_nsa | 3 | RISK | P0 | DONE | ANALYST | No Surprises Act exposure assessed (OON share + IDR arbitration exposure)? |
| risk_steward | 3 | RISK | P0 | DONE | ANALYST | Real-estate Steward Score computed (sale-leaseback risk + EBITDAR coverage)? |
| risk_team | 3 | RISK | P1 | OPEN | ANALYST | TEAM (CMS Transforming Episode Accountability) exposure reviewed? |
| risk_antitrust | 3 | RISK | P0 | DONE | LEGAL | Antitrust / HHI concentration check for the target's footprint? |
| risk_cyber | 3 | RISK | P0 | DONE | ANALYST | Cyber posture composite + BI-loss estimate produced? |
| risk_ma_v28 | 3 | RISK | P0 | DONE | ANALYST | Medicare Advantage V28 recalibration impact computed? |
| risk_physician_comp_fmv | 3 | RISK | P0 | DONE | LEGAL | Physician comp benchmarked against FMV p25/p50/p75 + Stark red-lines checked? |
| risk_labor_referral | 3 | RISK | P1 | OPEN | ANALYST | Labor + referral leakage reviewed (synthetic FTE, wage inflation, referral concentration)? |
| risk_patient_pay | 3 | RISK | P2 | OPEN | ANALYST | Patient-pay + reputational overlays reviewed? |
| fin_ebitda_bridge | 4 | FINANCIAL | P0 | DONE | ANALYST | EBITDA bridge with 7 levers built (denial reduction, coding uplift, contract yield, WC optimization, labor inflation, reg-headwind, cyber reserve)? |
| fin_deal_mc | 4 | FINANCIAL | P0 | DONE | ANALYST | Deal Monte Carlo run (3000 trials, 5-year forward MOIC/IRR distribution, variance attribution, sensitivity tornado)? |
| fin_counterfactual | 4 | FINANCIAL | P0 | DONE | PARTNER | Counterfactual Advisor — offer-shape modifications to flip every RED/CRITICAL finding? |
| fin_market_intel | 4 | MARKET | P1 | DONE | ANALYST | Public-operator comps + transaction multiples pulled for the target's category? |
| fin_working_capital_peg | 4 | FINANCIAL | P1 | OPEN | ANALYST | Normalised working-capital target estimated + reconciled to seller's proposed peg? |
| deliver_qoe | 5 | DELIVERABLE | P0 | OPEN | PARTNER | Quality-of-Earnings memo drafted and reviewed? |
| deliver_ic_packet | 5 | DELIVERABLE | P0 | OPEN | PARTNER | IC Packet assembled (12 sections with partner synthesis + walkaway + open questions)? |
| manual_mgmt_references | 3 | MANUAL | P1 | OPEN | PARTNER | Management team reference calls (CEO / CFO / RCM-ops director) completed? |
| manual_legal_review | 3 | MANUAL | P0 | OPEN | LEGAL | Seller legal review — corporate structure, equity rollover, reps + warranties — signed off? |
| manual_commercial_contract_review | 3 | MANUAL | P0 | OPEN | LEGAL | Commercial payer contract review — top-5 payer contracts' carveouts, escalators, termination clauses, auto-renewal? |
| manual_real_estate_title | 3 | MANUAL | P1 | OPEN | EXTERNAL | Real estate title + environmental + survey report for every owned facility? |
| manual_seller_disclosure | 3 | MANUAL | P1 | OPEN | LEGAL | Seller disclosure schedule review — pending litigation, regulatory audits, DOJ/OIG matters? |
| regulatory_calendar_scan | 3 | RISK | P0 | OPEN | ANALYST | Has the Regulatory Calendar × Thesis Kill-Switch been run to map upcoming CMS / OIG / FTC / DOJ / NSA-IDR events to the target's thesis drivers? |
| covenant_stress_simulation | 4 | FINANCIAL | P0 | BLOCKED | ANALYST | Has the Covenant & Capital Stack Stress Lab been run to quantify per-quarter covenant-breach probability and equity-cure sizing? |
| hcris_peer_xray | 1 | SCREENING | P0 | OPEN | ANALYST | Has the HCRIS-Native Peer X-Ray benchmarked the target against 25-50 filed Medicare cost reports? |
| payer_mix_stress | 3 | RISK | P1 | OPEN | ANALYST | Has the Payer Mix Stress Lab stress-tested the target's commercial + government payer portfolio? |
Press ? for shortcuts · b to bookmark · ⌘K to jump